Nu Skin Enterprises, Inc. (NUS) Earnings Call Transcripts

33 earnings calls from February 2020 to August 10, 2026

NYSE US Consumer Staples Personal Care Products

Nu Skin Enterprises, Inc.'s Latest Earnings Call - Q1 FY2026

In Q1 2026, Nu Skin Enterprises reported revenue of $320.6 million and adjusted earnings per share (EPS) of $0.14, both in line with expectations. The company maintained its annual guidance, projecting Q2 revenue between $330 million and $360 million and EPS of $0.15 to $0.25. Management highlighted progress in their intelligent Beauty and Wellness platform, particularly with the Prysm iO initiative, which is expected to drive future growth despite current macroeconomic pressures.

Reported metrics

MetricValueContext
Revenue $320.6 million (inline) in line with guidance
Adjusted EPS $0.14 (inline) in line with guidance
Adjusted Gross Margin 67.9% (beat) vs 67.8% YoY
Selling Expense 34.3% (negative) up from 32.5% YoY
Adjusted Operating Margin 3.6% (negative) down from 6.4% YoY
Q2 Revenue Guidance $330 million to $360 million (positive) reflecting sequential improvement

Guidance from management

Nu Skin maintained its annual guidance, expecting Q2 revenue between $330 million and $360 million and EPS of $0.15 to $0.25, indicating confidence in sequential improvement despite macroeconomic challenges.

What management said

Yes. And I'd just add and Ryan talked about this, and I mentioned it earlier as well. As far as our guidance model, we're not currently anticipating a significant impact. But as the increase in oil prices and other macroeconomic pressures are prolonged, then we're monitoring that as well. And we're continuing to look for ways that we can optimize our gross margin to offset and navigate these uncertain times. So not...
— Chelsea Lantz, Q1 FY2026 earnings call

What analysts pressed on

Analysts expressed concerns about the impact of macroeconomic pressures on consumer sentiment and spending. There were questions regarding how these factors could affect future sales and profitability, particularly in emerging markets like India.

Main topics on the call

Read the full Nu Skin Enterprises, Inc. transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Nu Skin Enterprises, Inc.

Nu Skin Enterprises, Inc. (NUS) is a publicly listed company in the Personal Care Products industry, within the Consumer Staples sector. It trades on NYSE and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 33 calls on record spanning February 12, 2020 to August 10, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 33 Nu Skin Enterprises, Inc. earnings call transcripts on record, spanning February 12, 2020 to August 10, 2026. Based on this history, Nu Skin Enterprises, Inc. reports quarterly. The most recent call on file is dated August 10, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
NUS
Exchange
NYSE
Country
US
Sector
Consumer Staples
Industry
Personal Care Products
Calls on record
33
First call
February 12, 2020
Most recent
August 10, 2026
Reporting cadence
quarterly
Quarter Date
Q2 FY2026 Aug 10, 2026 Read transcript
Q1 FY2026 May 7, 2026 Read transcript
Q4 FY2025 Feb 12, 2026 Read transcript
Q3 FY2025 Nov 6, 2025 Read transcript
Q2 FY2025 Aug 7, 2025 Read transcript
Q1 FY2025 May 8, 2025 Read transcript
Q4 FY2024 Feb 13, 2025 Read transcript
Company Conference Presentations Jan 14, 2025 Read transcript
Q3 FY2024 Nov 7, 2024 Read transcript
Q2 FY2024 Aug 8, 2024 Read transcript
Q1 FY2024 May 8, 2024 Read transcript
Q4 FY2023 Feb 14, 2024 Read transcript
Company Conference Presentations Jan 9, 2024 Read transcript
Q3 FY2023 Nov 1, 2023 Read transcript
Q2 FY2023 Aug 1, 2023 Read transcript
Q1 FY2023 May 3, 2023 Read transcript
Q4 FY2022 Feb 15, 2023 Read transcript
Q3 FY2022 Nov 2, 2022 Read transcript
Q2 FY2022 Aug 4, 2022 Read transcript
Q1 FY2022 May 4, 2022 Read transcript
Analyst/Investor Day Feb 16, 2022 Read transcript
Q3 FY2021 Nov 3, 2021 Read transcript
Q2 FY2021 Aug 4, 2021 Read transcript
Company Conference Presentations Jun 22, 2021 Read transcript
Q1 FY2021 May 5, 2021 Read transcript
Analyst/Investor Day Feb 11, 2021 Read transcript
Q3 FY2020 Nov 4, 2020 Read transcript
Q2 FY2020 Aug 5, 2020 Read transcript
Company Conference Presentations Jun 23, 2020 Read transcript
Company Conference Presentations Jun 10, 2020 Read transcript
Shareholder/Analyst Calls Jun 3, 2020 Read transcript
Q1 FY2020 May 6, 2020 Read transcript
Q4 FY2019 Feb 12, 2020 Read transcript